Regulatory T cells and progenitor B cells are independent prognostic predictors in lower risk myelodysplastic syndromes.
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
Josephine D
JD
Kahn
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
Martine E D
ME
Chamuleau
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
Theresa M
TM
Westers
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
Peter M
PM
Van de Ven
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
Linda
L
van Dreunen
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
Margot
M
van Spronsen
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
Gert J
GJ
Ossenkoppele
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands a.vandeloosdrecht@vumc.nl.
Arjan A
AA
van de Loosdrecht
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000175:diagnosis* / Q000276:immunology*; D054448:Precursor Cells, B-Lymphoid / Q000276:immunology*; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D012307:Risk Factors; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
myelodysplastic syndrome; progenitor B cells; prognosis; regulatory T cells